logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yongjun Fang

Nanjing Medical University
H指数:23
被引数:1,768

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The efficacy and safety of Huaiqihuang Granule in the treatment of childhood chronic primary immune thrombocytopenia: a multi-centre, randomized, double-blind, placebo-controlled clinical study(Han et al., 2024)

淮杞黄颗粒治疗儿童慢性原发性免疫性血小板减少症的有效性与安全性：一项多中心、随机、双盲、安慰剂对照的临床研究（Han et al., 2024）

Journal of Ethnopharmacology
IF5.4
2025-12-180
PRE
Juan Han; Qiang Fu; Changda Liang; Xiaojun Yuan; Xiaoli Zhang; Wenge Hao; Yanhua Yao; Yufeng Liu; Lirong Sun; Yongjun Fang; Rong Liu; Wenjun Liu; Jingyao Ma; Fen Zhou; Runming Jin
RISK-ADAPTED THERAPY FOR JUVENILE MYELOMONOCYTIC LEUKEMIA: A MULTICENTER, PROSPECTIVE STUDY IN CHINA
EJC Paediatric Oncology
IF0
2025-11-010
OAAI
Qin, Xia; Qin, Maoquan; Hu, Shaoyan; Yu, Jie; Xu, Xiaojun; Qu, Lijun; Zhu, Yiping; Chen, Sen; Sun, Ruijuan; Wang, Ningling; Xiong, Hao; Liu, Rong; Liu, Ansheng; Dou, Huihong; Mao, Yanna; Zhang, Benshan; He, Xiangling; Wang, Dao; He, Yunyan; Fang, Yongjun; Zhang, Rong; Wang, Xiaohuan; Pan, Kaili; Jiang, Hui; Dai, Yan; Hu, Qun; Wu, Xiaoyan; Feng, Xiaoqin; Zhao, Yanxia; Wang, Hongmei; Liu, Sixi; Ma, Futian; Fang, Jianpei; Zhu, Xiaofan; Lin, Yuchen; Miao, Yan; Jing, Chen
Risk factors for DIC in paediatric APL: Insights from the CCLG-APL 2016 study

儿童APL中DIC的危险因素：来自CCLG-APL 2016研究的见解

British Journal of Haematology
IF3.8
2025-10-230
PRE
Qingyuan Xu; Linya Wang; Shaoyan Hu; Ning Liao; Diying Shen; Xin Tian; Guoping Hao; Runming Jin; Jianxin Li; Yongjun Fang; Xiuli Ju; Ansheng Liu; Yuanyuan Zhang; Pengli Huang; Jiaole Yu; Ying Wu; Wei Lin; Peijing Qi; Jia Fan; Ruidong Zhang; Yaguang Peng; Huyong Zheng; for the Chinese Children's Leukemia Group
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study

中国急性白血病亚型在不同年龄组的发病率、死亡率和生存率：一项基于人群癌症登记的分析和队列研究

The Lancet Haematology
IF0
2025-10-060
PRE
Wei Yin; Xiaoyu Yan; Jiaoyang Cai; Bingfeng Han; Peng Yin; Gang Lu; Wenyan Cheng; Jianan Zhang; Huiyi Wu; Jiaqi Ren; Pengyu Ren; Zifang Zhou; Haibo Wang; Ying Shi; Lanxia Gan; Depei Wu; Jie Jin; Yongping Song; Zhongxing Jiang; Xiaojing Yan; Ting Niu; Yu Hu; Fei Li; Sujun Gao; Tao Cheng; Jianxiang Wang; Xi Zhang; Xiaojun Huang; Qifa Liu; Xiaoyu Zhu; Pengcheng He; Yuqing Chen; Tonghua Yang; Jianyong Li; Xudong Wei; Yongrong Lai; Jishi Wang; Jinsong Yan; Jie Yu; Xiaofan Zhu; Weiqun Xu; Yufeng Liu; Ju Gao; Hua Jiang; Yongzhi Zheng; Hua Wang; Yunyan He; Yongjun Fang; Shuhong Shen; Jing Chen; Bing Chen; Sujiang Zhang; Yang Shen; Jin Wang; Jianqing Mi; Weili Zhao; Hao Zhang; Maigeng Zhou; Wenqiang Wei; Jie He; Zhu Chen; Sai-Juan Chen
A Multicenter Study of Acute Abdomen in Children With Acute Lymphoblastic Leukemia: CCCG-ALL-2015

一项关于急性淋巴细胞白血病儿童急性腹痛的多中心研究：CCCG-ALL-2015

Cancer Medicine
IF3.1
2025-08-210
OAAI
Wenting Gan; Weina Zhang; Jiaoyang Cai; Xiaofan Zhu; Jie Yu; Peifang Xiao; Ju Gao; Yongjun Fang; Changda Liang; Xue Li; Fen Zhou; Xiaowen Zhai; Xiaoxiao Xu; Xin Tian; Aiguo Liu; Ningling Wang; Jiashi Zhu; Frankie Wai-Tsoi Cheng; Liangchun Yang; Ge Zhang; Shuhong Shen; Hua Jiang; Lingzhen Wang
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial

中剂量免疫耐受诱导方案相较于低剂量方案，具有更快的达标速度、更少的出血事件且不增加医疗成本：一项多中心随机对照临床试验

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
IF3.4
2025-01-010
OAAI
Li, Zhengping; Li, Zekun; Cheng, Xiaoling; Zhang, Heng; Yang, Can; Xu, Qian; Chen, Zhenping; Zhen, Yingzi; Li, Gang; Liu, Guoqing; Yao, Wanru; Zhou, Min; Jin, Jiao; Huang, Jie; Fang, Yongjun; Xie, Liangzhi; Poon, Man-Chiu; Wu, Runhui
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL

儿童ALL缓解诱导期间可测量残留疾病水平的预后和治疗意义

BLOOD
IF23.1
2024-12-300
PRE
Zhang, Weina; Cai, Jiaoyang; Wang, Xiang; Ma, Yani; Zhu, Xiaofan; Yu, Jie; Xiao, Peifang; Gao, Ju; Fang, Yongjun; Liang, Changda; Li, Xue; Zhou, Fen; Zhai, Xiaowen; Xu, Xiaoxiao; Tian, Xin; Liu, Aiguo; Wang, Ningling; Zhu, Jiashi; Wang, Lingzhen; Cheng, Frankie Wai-Tsoi; Yang, Liangchun; Zhang, Ge; Cheng, Cheng; Yang, Jun J.; Shen, Shuhong; Li, Chi-kong; Li, Benshang; Jiang, Hua; Pui, Ching-Hon
Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: A retrospective multicenter study
CANCER
IF5.1
2024-08-130
PRE
Zhang, Xiaoyan; Wang, Yaqin; Tian, Xin; Sun, Lirong; Jiang, Hua; Chu, Jinhua; Zhou, Fen; Shen, Shuhong; Hu, Shaoyan; Fang, Yongjun; Lai, Changcheng; Ju, Xiuli; Xu, Xiaoxiao; Zhai, Xiaowen; Jiang, Hui; Yang, Minghua; Leung, Alex W. K.; Xue, Ning; Zhang, Yingchi; Yang, Jun; Pui, Ching-Hon; Yu, Jie; Gao, Ju; Hu, Qun; Zhu, Xiaofan
Reduced doses of emicizumab achieve good efficacy: Results from a national-wide multicentre real-world study in China

减少剂量的emicizumab取得良好疗效: 来自中国全国范围的多中心真实世界研究的结果

HAEMOPHILIA
IF3
2024-06-092
PRE
Xu, Yuan; Wang, Ying; Wu, Runhui; Zheng, Changcheng; Zhang, Li; Xu, Weiqun; Feng, Xiaoqin; Wang, Hua; Cao, Xiangshan; He, Liya; Xue, Tianyang; Jin, Mingwei; Xie, Bingshou; Ling, Jing; Sun, Lirong; Su, Rui; Cheng, Hongbo; Fang, Yongjun; Poon, Man-Chiu; Liu, Wei; Zhang, Lei; Xue, Feng; Yang, Renchi
Outcome of infants with acute lymphoblastic leukemia treated with the Chinese Children's Cancer Group Acute Lymphoblastic Leukemia 2015 study protocol
HAEMATOLOGICA
IF7.9
2024-04-182
OAAI
Leung, Alex W. K.; Cai, Jiaoyang; Wan, Zhi; Qin, Jiefen; Fang, Yongjun; Sun, Lirong; Zhu, Jiashi; Hu, Shaoyan; Wang, Ningling; Gao, Pan; Tian, Xin; Zhu, Xiaofan; Zhou, Fen; Wu, Xuedong; Ju, Xiuli; Zhai, Xiaowen; Jiang, Hua; Hu, Qun; Liang, Changda; Yang, Liangchun; Zhang, Hui; Tang, Jingyan; Gao, Ju; Pui, Ching-Hon; Li, Chi-Kong

研究方向

暂未获取到该数据
J
Jiaoyang Cai
H 指数:16论文数:89被引数:1,347
N
Ningling Wang
H 指数:30论文数:130被引数:2,533
X
Xin Tian
H 指数:15论文数:83被引数:981
L
Liucheng Rong
H 指数:11论文数:41被引数:418
C
Changda Liang
H 指数:8论文数:39被引数:569
Y
Yao Xue
H 指数:20论文数:98被引数:1,277
X
Xiaofan Zhu
H 指数:33论文数:500被引数:6,990
X
Xiuli Ju
H 指数:25论文数:136被引数:2,507
L
Lirong Sun
H 指数:8论文数:37被引数:628
F
Fen Zhou
H 指数:18论文数:85被引数:1,599